- Home
- AVAL vs SLNO Comparison
AVAL vs SLNO Comparison
Compare AVAL & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAL
- SLNO
- Stock Information
- Founded
- AVAL 1994
- SLNO 1999
- Country
- AVAL Colombia
- SLNO United States
- Employees
- AVAL N/A
- SLNO N/A
- Industry
- AVAL Commercial Banks
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AVAL Finance
- SLNO Health Care
- Exchange
- AVAL Nasdaq
- SLNO Nasdaq
- Market Cap
- AVAL 3.2B
- SLNO 3.2B
- IPO Year
- AVAL N/A
- SLNO 2014
- Fundamental
- Price
- AVAL $2.80
- SLNO $76.88
- Analyst Decision
- AVAL
- SLNO Strong Buy
- Analyst Count
- AVAL 0
- SLNO 9
- Target Price
- AVAL N/A
- SLNO $103.33
- AVG Volume (30 Days)
- AVAL 138.9K
- SLNO 958.9K
- Earning Date
- AVAL 05-19-2025
- SLNO 05-07-2025
- Dividend Yield
- AVAL 3.87%
- SLNO N/A
- EPS Growth
- AVAL 195.30
- SLNO N/A
- EPS
- AVAL 0.01
- SLNO N/A
- Revenue
- AVAL $2,951,771,633.00
- SLNO N/A
- Revenue This Year
- AVAL $46.54
- SLNO N/A
- Revenue Next Year
- AVAL $8.90
- SLNO N/A
- P/E Ratio
- AVAL $10.58
- SLNO N/A
- Revenue Growth
- AVAL 14.20
- SLNO N/A
- 52 Week Low
- AVAL $1.94
- SLNO $36.93
- 52 Week High
- AVAL $3.32
- SLNO $80.91
- Technical
- Relative Strength Index (RSI)
- AVAL 58.07
- SLNO 65.60
- Support Level
- AVAL $2.66
- SLNO $72.23
- Resistance Level
- AVAL $2.84
- SLNO $80.99
- Average True Range (ATR)
- AVAL 0.10
- SLNO 3.04
- MACD
- AVAL 0.02
- SLNO -0.35
- Stochastic Oscillator
- AVAL 69.26
- SLNO 66.36
About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its segments include: Banking Services segment comprises Banking Services, fund management and trust businesses, storage companies and entities that manage low-value payment systems. Merchant Banking segment comprises Financial Sector (trust and brokerage), Gas and Energy Sector (includes natural gas and energy transportation and distribution businesses), Infrastructure Sector (includes road infrastructure projects, construction services, and operation and maintenance), Hotel Sector (includes hospitality services), Agribusiness Sector (includes palm oil, rubber and rice businesses). Pension and Severance Fund Management" segment comprise administrator of pension and severance funds; and Holding segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.